Monodisperse heterobifunctional PEGs of higher molecular weight for advanced pharmaceutical applications
Erik Agner, CEO Polypure AS The COVID-19 pandemic created a demand for a fast response to provide vaccines to a concerned world population. In this post, we will describe how Polypure developed monodisperse, heterobifunctional PEGs of higher molecular weights for advanced pharmaceutical applications based on the COVID-19 vaccine R&D project. The technology of mRNA incorporated … Read more